Occupational health issues in the pharmaceutical research and development process

Area of Science:

• Pharmaceutical Sciences
• Drug Discovery and Development
• Occupational Health and Safety

Background:

• Drug development is a lengthy process (8-12 years) involving multiple testing phases.
• Increased R&D stages correlate with a higher number of personnel potentially exposed to hazardous materials.
• Infectious organisms are key targets in drug development, posing unique risks.

Purpose of the Study:

• To provide a comprehensive overview of the drug research and development (R & D) pipeline.
• To identify and highlight potential occupational hazards associated with each stage of drug R & D.
• To guide researchers and industry professionals in mitigating risks during drug development.

Main Methods:

• Review of the standard drug research and development lifecycle.
• Analysis of potential exposure points for personnel to hazardous compounds and infectious agents.
• Identification of safety considerations throughout the R & D process.

Main Results:

• The R & D process involves numerous stages, each with specific safety challenges.
• Personnel may encounter risks from both chemical compounds and biological targets.
• Systematic hazard identification is crucial for worker safety.

Conclusions:

• Understanding the R & D process is key to managing occupational exposure risks.
• Proactive hazard identification and mitigation strategies are essential for safe drug development.
• This work serves as a guide for navigating safety protocols in pharmaceutical R & D.